NCT04116437 · Interventional trial
Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment
Overall registry status Completed
Phase 2
Conditions Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia
Delaware Valley sites
- Abington Hematology Oncology Associates · Horsham, PA · Montgomery County
First posted
Registry updated
Added to the directory